Back to news FoRx Therapeutics AG appoints Tarig Bashir as Chief Executive Officer Basel, Switzerland, 01 April, 2021 – FoRx Therapeutics, a recently incorporated privately-held company developing first-in-class compounds for cancer treatment, today announces the...
Back to news FoRx Therapeutics AG appoints Ulrich Lücking as Head of Chemistry Basel, Switzerland, 01 June, 2020 – FoRx Therapeutics, a recently incorporated privately-held company developing first-in-class compounds for cancer treatment, today announces the...
